Mirum Pharmaceuticals Total Non Current Liabilities 2011-2025 | MIRM

Annual Total Non Current Liabilities Mirum Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	50.3 M	3.29 M	59.8 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
59.8 M	3.29 M	37.8 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.9	4.03 %	$ 813 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Aclaris Therapeutics ACRS	5.95 M	$ 3.21	-1.38 %	$ 248 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Aptevo Therapeutics APVO	5 M	$ 1.06	-6.22 %	$ 293 K	USA
Catalyst Biosciences CBIO	981 K	$ 13.33	-5.39 %	$ 878 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	101 M	$ 214.55	-2.66 %	$ 5 B	Danmark
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.1	-5.93 %	$ 7.46 B	Australia
Celldex Therapeutics CLDX	17.3 M	$ 27.09	-1.53 %	$ 1.74 M	USA
Corcept Therapeutics Incorporated CORT	2.29 M	$ 88.51	0.59 %	$ 9.14 B	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 24.35	3.07 %	$ 2.88 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
CureVac N.V. CVAC	112 M	$ 5.02	-0.59 %	$ 934 M	Germany
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
BioVie BIVI	62.5 K	$ 1.43	-1.72 %	$ 2.11 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	341 M	$ 93.99	-0.86 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Dynavax Technologies Corporation DVAX	218 M	$ 10.88	0.74 %	$ 1.41 B	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 26.44	4.63 %	$ 1.28 B	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Anika Therapeutics ANIK	26.1 M	$ 9.6	0.42 %	$ 141 M	USA
Eton Pharmaceuticals ETON	4.56 M	$ 15.97	-4.37 %	$ 410 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.26	-6.9 %	$ 566 M	Israel
Evogene Ltd. EVGN	5.36 M	$ 1.04	-3.7 %	$ 27.9 M	Israel
Exelixis EXEL	63.6 M	$ 41.27	0.95 %	$ 12 B	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Foghorn Therapeutics FHTX	97.7 M	$ 4.39	-1.13 %	$ 241 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	107 M	$ 551.37	-2.29 %	$ 41.8 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.35	2.17 %	$ 14.8 M	USA
AstraZeneca PLC AZN	30.8 B	$ 91.19	1.51 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 11.25	-2.43 %	$ 728 M	USA
Biogen BIIB	9.03 B	$ 174.69	0.34 %	$ 25.4 B	USA